Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
publishDate:"[2021 TO 2021]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=9
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=9
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=9
PubPharm (1.746)
81
Pomalidomide/Dexamethasone With or Without Elotuzumab in Multiple Myeloma that is resistant to treatment. : An Open Label, Randomized Phase 2 Trial of Pomalidomide/Dexamethasone With or Without Elotuzumab in relapsed and refractory Multiple Myeloma.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
82
Assessment of the effect of a corticosteroids treatment in severe alcoholic hepatitis patients with early spontaneous improvement : Corticosteroids in patients with severe alcoholic hepatitis patients in early spontaneous improvement - Cortisave
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
83
Daratumumab Open label, dose-escalation safety study in Combination with Lenalidomide and Dexamethasone in Patients with multiple myeloma : An Open label, International, Multicenter, Dose Escalating Phase 1/2 Trial Investigating the Safety of Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma - Daratumumab in combination with lenalidomide and dexamethasone in relapsed and relapsed-refractory
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
84
It is an early clinical trial to assess a new drug (Melflufen) when giventogether with a steroid (Dexamethasone) in the treatment of patients with a disease called the AL AmyloidosisPatients should also have received treatment in the past for the disease. : An Open-Label, Phase 1/2 Study of Melflufen and Dexamethasone for Patients with AL Amyloidosis Following at Least One Prior Line of Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
85
A study evaluating safety and efficacy of itacitinib and corticosteroids as initial treatment of chronic graft versus-host disease : GRAVITAS-309: A Phase 2/3 Study of Itacitinib and Corticosteroids asInitial Treatment for Chronic Graft-Versus-Host Disease - GRAVITAS-309
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
86
A study evaluating safety and efficacy of Itacitinib or Placebo in combination with corticosteroids as initial treatment of chronic graft versus-host disease : GRAVITAS-309: A Phase 2/3 Study of Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease - GRAVITAS-309
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
87
It is an early clinical trial to assess a new drug (Melflufen) when giventogether with a steroid (Dexamethasone) in the treatment of patients with a disease called the AL AmyloidosisPatients should also have received treatment in the past for the disease. : An Open-Label, Phase 1/2 Study of Melflufen and Dexamethasone for Patients with AL Amyloidosis Following at Least One Prior Line of Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
88
A study of belantamab mafodotin compared to a combination of pomalidomide and dexamethasone in participants with relapsed/refractory multiple myeloma : A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide plus Low-dose Dexamethasone (pom/dex) in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
89
Efficacy and safety of intra-articular botulinum toxin A versus corticosteroid injections in knee osteoarthritis: A randomised control trial : Efficacy and safety of intra-articular botulinum toxin A versus corticosteroid injections in knee osteoarthritis: A randomised control trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
90
Efficacy and safety of lebrikizumab in patients with AD not adequately controlled or non-eligible for cyclosporine : A Randomised, Double-Blind, Placebo-Controlled Phase 3 Clinical Trial to Assess the Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adult and Adolescent Patients With Moderate-To-Severe Atopic Dermatitis That Are Not Adequately Controlled With Cyclosporine or For Whom Cyclosporine is Not Medically Advisable. - ADvantage
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
[1]
« Vorheriger
4
5
6
7
8
9
10
11
12
13
14
Nächster »
[175]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Erscheinungsjahr: 2021-2021
Medienart
1.746
Aufsätze
1.746
E-Artikel
1.746
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
1.724
610
1.664
Study Type: Interventional
778
Recruitment Status: Not yet recruiting
506
Phase: Phase 3
344
Recruitment Status: Authorised-recruitment may ...
284
Recruitment Status: Completed
272
Phase: Phase 2
242
Recruitment Status: Recruiting
138
Phase: Phase 4
74
Phase: Phase 1
70
Medical Condition: Health Condition 1: O- Medic...
50
Study Type: Observational
48
Medical Condition: Multiple Myeloma MedDRA vers...
42
Phase: Phase 2/Phase 3
28
Medical Condition: Multiple myeloma MedDRA vers...
28
Phase: Post Marketing Surveillance
24
Medical Condition: Moderate and Severe Atopic D...
22
Medical Condition: Relapsed or Refractory Multi...
22
Medical Condition: corticosteroid-refractory ac...
20
Phase: Phase 3/Phase 4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2021-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.688
Englisch
54
Unbestimmt
4
Spanisch
Haven't found what you're looking for?
Wird geladen...